Y-Intercept (HK)’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109K Buy
+58,152
New +$154K ﹤0.01% 1607
2025
Q3
Sell
-224,456
Closed -$163K 1869
2025
Q2
$163K Buy
+224,456
New +$169K ﹤0.01% 1489
2024
Q4
Sell
-12,404
Closed -$35.4K 1496
2024
Q3
$35.4K Sell
12,404
-11,512
-48% -$29.8K ﹤0.01% 1231
2024
Q2
$56K Buy
+23,916
New +$62.4K ﹤0.01% 1295
2022
Q2
Sell
-16,106
Closed -$70K 1079
2022
Q1
$70K Buy
+16,106
New +$66.1K 0.02% 688

Other funds holding NAUT

Y-Intercept (HK)'s NAUT Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 58,152 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #1607 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in NAUT as recently as Q2 2025.

Y-Intercept (HK) first reported a position in NAUT in Q1 2022 and has held it in 5 quarters since. The position peaked at $163K in Q2 2025. 17 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Y-Intercept (HK) held 58,152 shares of Nautilus Biotechnolgy worth $109K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Y-Intercept (HK) position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1607 holding.
  • Y-Intercept (HK) first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 5 quarters since.
  • Y-Intercept (HK)'s Nautilus Biotechnolgy position peaked at $163K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.